Sabrina Gloria Giulia Testoni

Dr. Sabrina Gloria Giulia Testoni

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 February 2012 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
AMAlberto Mariani
Alberto Mariani
AGAntonella Giussani
Antonella Giussani
MLMilena Di Leo
Milena Di Leo
STSabrina Gloria Giulia Testoni
Sabrina Gloria Giulia Testoni
PTPier Alberto Testoni
Pier Alberto Testoni

1 August 2011 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PTPier Alberto Testoni
Pier Alberto Testoni
STSabrina Gloria Giulia Testoni
Sabrina Gloria Giulia Testoni
AGAntonella Giussani
Antonella Giussani


19 January 2023 in Life
Verified
Journal Article
Open access
PDF file
FMFrancesco Vito Mandarino
Francesco Vito Mandarino
ABAlberto Barchi
Alberto Barchi
Ferdinando D'AmicoFerdinando D'Amico
Ferdinando D'Amico
LFLorella Fanti
Lorella Fanti
FAFrancesco Azzolini
Francesco Azzolini
SDSilvio Danese
Silvio Danese
Background: Endoscopic treatment of post-esophagectomy/gastrectomy anastomotic dehiscence includes Self-Expandable Metal Stents (SEMS), which have represented the “gold standard” for many years, and Endoscopic Vacuum Therapy (EVT), which was recently introduced, showing promising results. The aim of the study was to compare outcomes of SEMS and EVT in the treatment of post-esophagectomy/gastrectomy anastomotic leaks, focusing on oncologic surgery. Methods: A systematic search was performed on Pubmed and Embase, identifying studies comparing EVT versus SEMS for the treatment of leaks after upper gastro-intestinal surgery for malignant or benign pathologies. The primary outcome was the rate of successful leak closure. A meta-analysis was conducted, performing an a priori-defined subgroup analysis for the oncologic surgery group. Results: Eight retrospective studies with 357 patients were eligible. Overall, the EVT group showed a higher success rate (odd ratio [OR] 2.58, 95% CI 1.43–4.66), a lower number of devices (pooled mean difference [pmd] 4.90, 95% CI 3.08–6.71), shorter treatment duration (pmd −9.18, 95% CI −17.05–−1.32), lower short-term complication (OR 0.35, 95% CI 0.18–0.71) and mortality rates (OR 0.47, 95% CI 0.24–0.92) compared to stenting. In the oncologic surgery subgroup analysis, no differences in the success rate were found (OR 1.59, 95% CI 0.74–3.40, I2 = 0%). Conclusions: Overall, EVT has been revealed to be more effective and less burdened by complications compared to stenting. In the oncologic surgery subgroup analysis, efficacy rates were similar between the two groups. Further prospective data need to define a unique management algorithm for anastomotic leaks.

1 March 2015 in Digestive and Liver Disease
Verified
Journal Article
Closed access
Giulia Martina CavestroGiulia Martina Cavestro
Giulia Martina Cavestro
GLGioacchino Leandro
Gioacchino Leandro
MLMilena Di Leo
Milena Di Leo
RZRaffaella Alessia Zuppardo
Raffaella Alessia Zuppardo
OMOlivia B. Morrow
Olivia B. Morrow
PTPier Alberto Testoni
Pier Alberto Testoni